Goldman Sachs’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Goldman Sachs’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-602,888	Closed	-$14.5M	–	7490
2014 Q2	$14.5M	Buy	602,888 +536,441	+807%	+$5.59M	﹤0.01%	2064
2014 Q1	$400K	Buy	66,447 +14,825	+29%	+$103K	﹤0.01%	5480
2013 Q4	$308K	Sell	51,622 -20,841	-29%	-$96.4K	﹤0.01%	5676
2013 Q3	$376K	Sell	72,463 -74,479	-51%	-$326K	﹤0.01%	5394
2013 Q2	$530K	Buy	+146,942	New	+$601K	﹤0.01%	4897

Goldman Sachs's IDIX Position: Q3 2014 in Review

Goldman Sachs sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 602,888 shares — an estimated $14.5M sold.

Goldman Sachs first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $14.5M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Goldman Sachs reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Goldman Sachs sold 602,888 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $14.5M.
Goldman Sachs first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
Goldman Sachs's IDENIX PHARMACEUTICALS INC position peaked at $14.5M in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Goldman Sachs's 13F filing for Q3 2014, filed 14 Nov 2014.